BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7609922)

  • 21. Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor.
    Colamonici OR; D'Alessandro F; Diaz MO; Gregory SA; Neckers LM; Nordan R
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7230-4. PubMed ID: 2144902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections.
    Horikoshi Y; Sasaki A; Taguchi N; Maeda M; Tsukagoshi H; Sato K; Yamaguchi H
    Acta Neuropathol; 2003 Feb; 105(2):157-62. PubMed ID: 12536226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a linear epitope of interferon-alpha2b recognized by neutralizing monoclonal antibodies.
    Blank VC; Sterin-Prync A; Retegui L; Vidal A; Criscuolo M; Roguin LP
    Eur J Biochem; 1999 Oct; 265(1):11-9. PubMed ID: 10491153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMEM119 marks a subset of microglia in the human brain.
    Satoh J; Kino Y; Asahina N; Takitani M; Miyoshi J; Ishida T; Saito Y
    Neuropathology; 2016 Feb; 36(1):39-49. PubMed ID: 26250788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
    Wojtera M; Sobów T; Kłoszewska I; Liberski PP; Brown DR; Sikorska B
    Folia Neuropathol; 2012; 50(1):74-84. PubMed ID: 22505366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the alpha subunit of the IFN-alpha receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins.
    Platanias LC; Pfeffer LM; Cruciani R; Colamonici OR
    J Immunol; 1993 Apr; 150(8 Pt 1):3382-8. PubMed ID: 8468477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
    Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
    J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homology model of human interferon-alpha 8 and its receptor complex.
    Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
    Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex.
    Constantinescu SN; Croze E; Wang C; Murti A; Basu L; Mullersman JE; Pfeffer LM
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9602-6. PubMed ID: 7524081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease.
    Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Moroo I; Yang J; Jefferies WA
    Brain Res; 1999 Oct; 845(1):1-5. PubMed ID: 10529437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
    Kerkmann M; Rothenfusser S; Hornung V; Towarowski A; Wagner M; Sarris A; Giese T; Endres S; Hartmann G
    J Immunol; 2003 May; 170(9):4465-74. PubMed ID: 12707322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFNA2 p.Ala120Thr impairs the inhibitory activity of Interferon-α2 against the hepatitis B virus through altering its binding to the receptor.
    Chen C; Zhu X; Xu W; Yang F; Zhang G; Wu L; Zheng Y; Gao Z; Xie C; Peng L
    Antiviral Res; 2017 Nov; 147():11-18. PubMed ID: 28958921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.
    Ogawa K; Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Fujino Y; Nakajima M; Yamamoto T; Akatsu H; Mitsui S; Yamaguchi N
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):419-26. PubMed ID: 10997858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against IFN gamma-binding proteins recognize a member of IFN alpha R complex.
    Bello I; Rodes L; Saura PL
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1197-202. PubMed ID: 11162654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease.
    Honda M; Akiyama H; Yamada Y; Kondo H; Kawabe Y; Takeya M; Takahashi K; Suzuki H; Doi T; Sakamoto A; Ookawara S; Mato M; Gough PJ; Greaves DR; Gordon S; Kodama T; Matsushita M
    Biochem Biophys Res Commun; 1998 Apr; 245(3):734-40. PubMed ID: 9588184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
    Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
    Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
    J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockage of CR1 prevents activation of rodent microglia.
    Crehan H; Hardy J; Pocock J
    Neurobiol Dis; 2013 Jun; 54():139-49. PubMed ID: 23454195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.